Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Gains from Investment Securities (2024 - 2025)

Historic Gains from Investment Securities for CG Oncology (CGON) over the last 2 years, with Q1 2025 value amounting to $859000.0.

  • CG Oncology's Gains from Investment Securities fell 8897.1% to $859000.0 in Q1 2025 from the same period last year, while for Sep 2024 it was $7.7 million, marking a year-over-year change of. This contributed to the annual value of $221000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that CG Oncology reported Gains from Investment Securities of $859000.0 as of Q1 2025, which was down 8897.1% from $7.7 million recorded in Q3 2024.
  • In the past 5 years, CG Oncology's Gains from Investment Securities ranged from a high of $7.8 million in Q1 2024 and a low of $859000.0 during Q1 2025